Mongolia Receives National Productivity Master Plan (2026–35) to Drive Productivity-led Growth, Resilience, and Shared Prosperity
Notified -
Globe Newswire28-01-2026, 11:41
FDA Approves Expanded Indication for AJOVY® (fremanezumab-vfrm), The First Anti-CGRP Preventive Treatment for Pediatric Episodic Migraine 6-08-2025, 18:00